Delivery Order SPE2DB20D3101-SPE2DB22FQVB5
Award Date
9/15/22
Potential Completion Date
9/16/22
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,162.44 firm fixed-price contract is for the delivery of Tresiba FlexTouch 200 unit/ml 3ml insulin pens, with a period of performance through July 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of Tresiba FlexTouch insulin pens, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,484.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with a completion date of November 29, 2024. The contract is not designated as a set-aside and represents a direct procurement under AmerisourceBergen's existing Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 31, 2024. The $1,656.60 firm fixed-price delivery order is for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin pens. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This federal contract award is for the delivery of Tresiba FlexTouch insulin therapy products to the Defense Logistics Agency (DLA) Troop Support Medical, a major acquisition center within the Department of Defense. The $2,269 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor, to supply 200 unit/mL, 3 mL insulin pens. The award is a delivery order issued under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,781.95 award is for a delivery order to supply Tresiba Flextouch insulin pens, a specialty medication. The contract is a firm fixed-price arrangement with a performance period ending on August 9, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The $3,002.58 Firm Fixed Price delivery order was awarded on April 21, 2022 with an ultimate completion date of April 22, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Tresiba Flextouch 200 unit/mL 3mL insulin delivery pens. The single-award Delivery Order, valued at $15,711.19, has a firm fixed price and was not designated with a set-aside requirement. The contract has an ultimate completion date of April 26, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Tresiba FlexTouch 200 unit/mL 3mL insulin pens to the government. The $2,510.07 firm fixed price contract with AmerisourceBergen Drug Corp does not have a set-aside designation, indicating an open competition. The contract is a delivery order that is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba Flextouch insulin pens. The $7,699.35 firm fixed price contract has an ultimate completion date of August 21, 2024. This order is part of a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 100 unit/mL 3mL insulin pens. The contract has a ceiling value of $2,001.06 and is a firm-fixed price delivery order, with a period of performance ending on July 11, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...